Biomega
Laboratories, Inc. is a Delaware C corporation based in New York
City. To date Biomega's endeavors have been financed by individual
investors who believe in the humanitarian and medical potential
of CIF.
The
Company is lead by its Chairman, Rudolph Kindel, its CEO and President,
Richard Glaser and its capable Board.
-
Chairman - Rudolph Kindel, a NJ business man, is Biomega's
founder and original angel investor.
-
CEO, President - Richard D. Glaser, Ph.D. has pharmaceutical
industry experience including product development, regulatory
affairs, clinical drug development, marketing, and management.
-
Member - Richard E. Stierwalt, MBA is President, Chief
Executive Officer and a Director of DCFG, a globally-focused
firm offering alternative investment products.
-
Member - Mark A. Krentzman, MBA has experience as an
entrepreneur and business consultant, offering financial and
operational expertise to small and medium-sized businesses.
-
Member - Kenneth Apfel, JD is an attorney at law at
Shapiro & Croland.
-
Member - Michael J. Byl is founder of Palladium Global
Partners LLC, providing support services to investment management
firms and serves as President of Greenfield Capital Partners
LLC.
-
Member - Robin L. Smith, MD, MBA, is an entrepreneur
acting as a senior advisor and investor in publicly traded
and privately held companies. In addition she is the Co-chairman
of the Board of the NYUSM/New York University Hospital for
Joint Diseases.
To
learn more, please contact:
Biomega Laboratories, Inc.
In
Care of: Richard D. Glaser, Ph.D.
NYC Phone: (212) 307-4386 | CT Phone: (203) 838-6918
| Mobile Phone: (917) 975-8400
Email: rdglaser@earthlink.net.
|
|
